...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AACR April 24-29, 2020 for some Zenith Clinical Trial Results?

Thx to tada and GP I found the PM I sent Feb11th.I was not far out in my memory.The first cohort started in August the 1st scan showed a 56 percent shrink the 2 scan 30 percent the 3rd remision

Share
New Message
Please login to post a reply